Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L18a pseudogene 8 (RPL18AP8) is a human processed pseudogene related to the ribosomal protein L18a gene. While the parent gene RPL18A encodes a structural component of the 60S ribosomal subunit, RPL18AP8 itself is classified as a non-functional pseudogene and does not encode a protein product. Its genomic location is on chromosome 3 (3q11.1). As a processed pseudogene, it is not known to have any active biological function or direct implication as a therapeutic target, nor is it directly linked to human disease or drug interactions. There are many ribosomal protein pseudogenes, and while some pseudogenes have emerging regulatory or disease biomarker roles—including in cancer—there is currently no evidence for RPL18AP8 having such functions. Most information available confirms its classification as a typical, non-functional processed pseudogene rather than an active therapeutic or biological target. The commonly used abbreviation is RPL18AP8, and it is also listed as RPL18A_3_387 in some databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L18a pseudogene 8 (RPL18AP8).